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Schema Therapy has shown promising results for personality disorders but there
is a limited evidence base for group schema therapy (ST-g) with mixed personality
disorders. The aim of this study was to explore the feasibility, acceptability, and
preliminary effectiveness of ST-g in a sample of eight participants with mixed personality
disorders (with a predominant diagnosis of avoidant personality disorder) and high levels
of comorbidity. Treatment was comprised of 20 sessions which included cognitive,
behavioral, and experiential techniques. Specific schema-based strategies were chosen
for a diagnostically mixed group of personality disorder clients. Six participants attended
until end of treatment and two dropped-out before mid-treatment. All outcome measures
showed changes with large effect sizes in avoidant personality disorder symptom severity,
depression and anxiety levels between pre-therapy and follow-up. Four participants
achieved a loss of personality disorder diagnosis at the end of therapy. By follow-up,
five participants had achieved a loss of diagnosis, suggesting that participants derived
ongoing benefits from the group even after treatment ended. Six participants no longer
met criteria for depression at the end of treatment and this was maintained for all
participants at 6-month follow-up. At follow-up, the majority of participants showed
clinically significant change on the Global Symptom Index (GSI). For the Schema Mode
Inventory (SMI) maladaptive modes, the majority of participants showed improvement at
follow-up. At follow-up, 40% of participants showed clinically significant change on the
SMI adaptive modes. Qualitative feedback indicates that the group helps to normalize
participants’ psychological experiences and difficulties and promotes self-expression and
self-disclosure, while reducing inhibition. Preliminary results suggest that short-term ST-g
may benefit those with mixed personality disorders, but generalizability is limited by the
small sample size and lack of control group.
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INTRODUCTION
Personality disorders are highly prevalent in clinical settings.
Approximately one-third of clients in outpatient clinical settings
are diagnosed with a personality disorder (Zimmerman et al.,
2005). The majority of individuals diagnosed with a personality
disorder meet criteria for more than one. Avoidant, border-
line, and obsessive-compulsive personality disorders are among
the most frequently specified diagnoses (Zimmerman et al.,
2005). Personality disorders are notoriously difficult to treat and
often require long-term treatment with psychotherapy (National
Institute of Clinical Excellence, 2009). One psychotherapy that
shows promise for effectively treating a range of personality
disorders is Schema Therapy.
Schema Therapy (ST) is one of the third wave innovative
therapies that have developed specifically for treating personal-
ity disorders and other complex, chronic clinical presentations.
ST has proven to be an efficacious and cost effective treatment for
Borderline Personality Disorder (BPD) (Giesen-Bloo et al., 2006;
van Asselt et al., 2008; Farrell et al., 2009; Nadort et al., 2009;
Masley et al., 2011). A multicenter randomized controlled trial
(RCT; Giesen-Bloo et al., 2006) with 86 patients compared ST to
Transference-Focused Psychotherapy (TFP) over a 3 year period
(with a follow-up 1 year later). ST was more effective than TFP
both in terms of recovery from BPD and all outcome measures,
and had a lower rate of dropouts over 3 years (27% vs. 50%). ST
also proved to be more cost effective than TFP (less costs and
better effects) (van Asselt et al., 2008). Another study, Nadort
et al. (2009) found ST to be superior to treatment as usual (TAU)
for BPD. In light of the promising results for ST with BPD, the
application of ST is currently being extended to other personal-
ity disorders, treatment settings, and client populations. A recent
RCT found ST was more effective than clarification-oriented psy-
chotherapy for cluster C personality disorders (Bamelis et al.,
2014). Another RCT, Ball et al. (2011) compared dual-focus
schema therapy with individual drug counseling as adjuncts to
treatment as usual in a population of 105 substance depen-
dent patients with personality disorders. The study found that
there was a comparable symptom reduction in both conditions;
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however, drop-out rates were high across conditions and individ-
ual drug counseling resulted in more sustained reductions than
did dual-focus schema therapy in several symptoms for several
personality disorders. Aside from this, only a handful of pre-
liminary studies have investigated the effectiveness of ST in the
treatment of personality disorders other than BPD, with very few
in group settings (e.g., Simpson et al., 2010; van Vreeswijk et al.,
2012; Renner et al., 2013; Videler et al., 2014).
The emergence of group therapy protocols has been an impor-
tant development in the growth of ST. It is thought that group
therapy provides important curative factors, including correc-
tive emotional learning experiences, a unique opportunity for
clients to practice new behavioral and coping skills in a de-
shaming environment, and opportunities for vicarious learning
(Farrell et al., 2009). In a study which compared a group schema
therapy approach (Group ST) to TAU, Farrell and Shaw found
Group ST demonstrated significantly larger treatment effects,
fewer dropouts, shorter duration, and required less therapist time
(Farrell et al., 2009). Similar promising results were found in a
pilot study (Dickhaut and Arntz, 2013) assessing the effective-
ness of a combination of individual and group schema ther-
apy for BPD patients provided over a 2 year period. A shorter
group schema cognitive behavioral therapy (SCBT-g) approach
has been developed by van Vreeswijk and Broersen (2006, 2013)
and successfully piloted in eating disorder patients (Simpson
et al., 2010). In a more recent study of 63 patients, SCBT-g
was associated with changes on all outcome measurements with
moderate to high effect sizes, with 53.2% of the patients show-
ing a significant reduction in severity of psychiatric symptoms
and schemas and modes. Compared to the Group ST model of
Farrell and Shaw (1994, 2012), Farrell et al. (2014), the SCBT-g
therapy is more structured and focuses more on the original
schema model whereas the Group ST model of Farrell and Shaw
focuses more on schema modes. An international multicenter
RCT is currently underway investigating Group ST for BPD using
the protocol developed by Farrell and Shaw (2012). Moreover,
a multicenter trial comparing group schema therapy to tradi-
tional group CBT for patients with generalized social phobia and
comorbid avoidant personality has commenced (Greeven et al.,
2013).
Preliminary evidence supports the use of ST in group treat-
ment for BPD; however, evidence supporting the use of group
schema therapy with patients with other personality disorders
is sparse. This paper described a pilot study using short-term
group schema therapy (ST-g) in a case series of eight patients
with Cluster A, B, and C personality disorders and high levels of
comorbidity.
DESIGN
The present study utilized a single group pre- and post-pilot study
in order to investigate the outcome of ST-g for a group of partici-
pants withmixed personality disorders in an outpatient university
clinic. The aim of this study was to explore the feasibility, accept-
ability, and preliminary effectiveness of ST-g. This pilot study is a
requisite initial step in informing the feasibility of a larger scale
study investigating the efficacy of ST-g in patients with mixed
personality disorders.
METHOD
PARTICIPANTS
Informed consent was obtained from all patients and ethics
approval was granted. Patients were referred to the group from
the University of South Australia psychology clinic, private psy-
chologists, and non-government organizations. Patients were
included if they met criteria for at least one personality disor-
der as assessed following the DSM-IV TR (American Psychiatric
Association, 1994) criteria and had already attended at least one
other evidence-based therapy. Patients were excluded if they were
experiencing acute psychotic symptoms, emotional crises which
required immediate treatment, severe drug use and untreated
substance dependence. Assessments were carried out by Master’s
level clinical psychology trainees and were recorded so that they
could be reviewed (and diagnoses verified) by a doctoral level
Clinical Psychologist and accredited schema therapy trainer and
supervisor. TheMaster’s level (group) therapists conducted initial
intake interviews in order to begin to build rapport with par-
ticipants with the aim of increasing engagement in the group
process. Participants were required to cease all other psycholog-
ical treatment for the duration of the group. Participants paid a
subsidized weekly session fee ($15 AUD). Two participants were
diagnosed with BPD, five with avoidant personality disorder and
one met criteria for avoidant personality disorder with comorbid
schizoid and dependent personality disorders. As can be seen in
Table 1, all participants had been treated using a minimum of one
evidence-based therapy for at least a year with the average dura-
tion of previous treatment being 2.4 years. All participants had
a diagnosis of major depressive disorder and seven had clinically
significant symptoms of anxiety. No participants were taking anti-
depressant medication at any stage of therapy. Table 1 gives basic
demographic details of the eight participants and the number of
sessions attended.
TREATMENT
The treatment was adapted from van Vreeswijk and Broersen’s
(2013) group schema cognitive-behavioral therapy protocol
(SCBT-g; van Vreeswijk and Broersen, 2013) but with a signifi-
cantly greater emphasis on schema mode work and experiential
change techniques. The original protocol consisted of eighteen,
90-min weekly sessions with two booster sessions. From the start
of the group participants are supported to connect with each
other and to create a safe group climate. The first phase of the
group focuses on educating clients about the schema model with
a focus on their top three schemas and modes. Each week the par-
ticipants rate the severity of their top three schemas and modes
with a focus on reducing the severity of their schemas and modes
over the duration of therapy. Schema Mode change strategies are
used to increase awareness of schemas and modes, such as identi-
fying mode triggering and challenging the parent modes. Schema
mode diaries and flashcards are used to challenge schemas and
work on behavioural change within and outside the therapy
group. Experiential and interpersonal techniques, such as lim-
ited reparenting, chair work and empathic confrontation are also
employed. In the second phase of the group, behavioral change
techniques, including role plays with healthy adult vs. schemas,
cost-benefit analysis, and pie charts are used.
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Table 1 | Sociodemographic data.
DSM-IV MCMI-III clinical Previous Age Occupation Education Marital Sessions
TR axis II syndromes treatment level status attended
diagnoses (years)
1 Avoidant Major depression,
anxiety
3 28 Student Honors degree Single 19
2 Avoidant Major depression,
anxiety
4 47 Unemployed Secondary school Single 16
3 Avoidant, schizoid
and dependent
Major depression,
anxiety
3 37 Unemployed Secondary school Single 19
4 Avoidant Major depression,
anxiety
1.5 25 Student Honors degree Single 20
5 Avoidant Major depression,
anxiety, somatization
1 29 Unemployed Diploma De facto
relationship
20
6 Avoidant Major depression,
anxiety
2 42 Unemployed Year 9,secondary school Widowed 17
7 Borderline Major depression,
anxiety
3 27 Hospitality Completing bachelor degree Single 1
8 Borderline Major depression 2 35 Health services Bachelor degree Relationship 8
MCMI-III, Millon Clinical Multiaxial Inventory; Third Edition (MCMI-III; Millon et al., 2006).
Our adapted model had a strong focus on experiential tech-
niques and mode work for a diagnostically mixed group of
personality disorder patients (with a predominant diagnosis of
Avoidant personality disorder). ST-g consisted of twenty, 60-min
sessions that were run weekly (for 5 months). It was a closed ther-
apy group with provision of five individual sessions during the
course of therapy. Sessions were recorded and participants who
missed sessions were required to watch the recording before the
next session. All sessions were delivered by the same two thera-
pists. Group therapists received one hour of weekly supervision
from a doctoral level Clinical Psychologist and accredited schema
therapy trainer and supervisor. Consultation was also provided by
the fourth author (van Vreeswijk).
The reparenting approach allowed participants to develop a
sense of interconnectedness and safety in the initial stages, and
in the later stages therapists encouraged participants to develop
independence, autonomy, and healthy assertiveness skills in order
to meet their emotional needs. Therapists helped participants
to develop skills in recognizing their own needs better and to
find healthier ways of getting these needs met. In the later stage
of treatment, the focus was on motivating and encouraging
behavioral change in the present. The “re-familying” compo-
nent involves the group being encouraged to function as a family
where the therapists become a parent figure by reparenting the
client, and other group members adopt supportive sibling roles
(Farrell and Shaw, 2012). Participants were strongly encouraged
to express emotions and ask for the group tomeet their emotional
needs, rather than coping by detaching from their needs, thoughts
and feelings.
We selected specific schema mode focused techniques on
the basis of predominant schema modes. Treatment strategies
focused on reducing highly avoidant coping mechanisms (i.e.,
Avoidant/Detached Protector) by using experiential and phys-
ical movement exercises to bypass coping. Participants were
encouraged to recognize and label the Detached Protector mode
when it was active during sessions and when talking about
avoidant behavior that had taken place between sessions. To chal-
lenge excessively high standards and self-criticism (Demanding
Parent), group chair work exercises and group role plays were
used. Limited reparenting and “re-familying” exercises were used
with child modes (e.g., group imagery). Due to a lack of emo-
tional awareness and emotional tolerance within the group there
was an additional focus on increasing awareness, tolerance, and
expression of emotions (i.e., Vulnerable Child mode, Healthy
Adult mode) e.g., emotion-focused and acceptance exercises. To
further increase awareness of schemas and modes and to facil-
itate emotion regulation, schema-focused mindfulness exercises
and regular “mode check-points” (a brief mode awareness exer-
cise) were also incorporated (Kristeller et al., 2006; van Vreeswijk
et al., 2014).
Both group therapists had more than 12 months of experi-
ence in providing ST to clients with personality disorders and
other complex difficulties under the supervision of an accredited
schema therapy trainer and supervisor, who regularly observed
their psychological therapy skills and checked for treatment
fidelity. Both group therapists had attended over 6 days of training
in ST.
MEASURES
The Millon Clinical Multiaxial Inventory (MCMI-III; Millon
et al., 2006) is a self-report questionnaire designed to assess psy-
chopathology, including specific disorders in the DSM-IV. The
diagnostic criteria and items used in the MCMI-III inventory
parallel that of the DSM-IV (Craig, 2005). Internal consistency
of the MCMI-III has been found to be good (0.70–0.80 range),
and the test–retest reliability is reported to be good to excellent
(around 0.85) (Craig, 2005). Convergent validity and divergent
validity have also been found to be good. According to the second
edition of the MCMI-III manual (Millon et al., 1997), and using
a cut-off of BR= 85, elevated scores on the Personality Scales and
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Clinical Syndrome Scales provide strong evidence of Axis I and II
disorders.
The Young Schema Questionnaire: Short form, second version
(YSQ-S2) (Young, 1998) is a 75-item self-report questionnaire
that measures 16 core beliefs (early maladaptive schemas). The
YSQ-S2 is derived from the original 205-item version (Young and
Brown, 1994). Respondents’ rate core beliefs regarding oneself or
one’s relation to others on a six-point scale ranging from 1 (com-
pletely untrue of me) to 6 (describes me perfectly). Research has
shown that the YSQ-S2 has good reliability and convergent and
discriminant validity (e.g., Schmidt et al., 1995; Rijkeboer et al.,
2005). The YSQ-S2 was used to measure change in strength of
schemas throughout treatment.
The SchemaMode Inventory (SMI; Young et al., 2007) is a 118-
item self-report questionnaire that measures 14 schema modes.
Lobbestael et al. (2010) have shown that the SMI has excellent
test–retest reliability and satisfactory divergent validity. The inter-
nal consistencies of the subscales of the SMI have been found to be
good to excellent (a ranging from 0.79 to 0.96), and the test–retest
reliability is reported to be excellent (Lobbestael et al., 2010). The
convergent validity and the divergent validity of the SMI sub-
scales are satisfactory. In the current study we categorized modes
into two categories: adaptive schema modes (Healthy Adult and
Happy Child) and maladaptive schema modes (all other modes).
The SMI was used to measure change in strength of schema
modes throughout treatment.
The Symptom Checklist 90-R (SCL-90-R; Derogatis et al.,
1973) is a 90-item self-report questionnaire designed to evalu-
ate a broad range of psychological problems and symptoms of
psychopathology. The SCL-90-R is widely used to measure par-
ticipant progress and treatment outcome. Internal consistency of
the SCL-90-R has been found to be good to excellent (a rang-
ing from 0.77 to 0.96), and the test–retest reliability is reported to
be good (Müller et al., 2010). Convergent validity and divergent
validity have been found to be good. In this study we have used
the SCL-90-R as a measure of general psychological distress.
PROCEDURE
The YSQ-S2, SMI, and the SCL-90-R were administered at pre-
treatment, at mid-treatment (session 10), at end of treatment, and
at 6-month follow-up. The MCMI-III was only administered at
pre-treatment, at the end of treatment, and at 6-month follow-
up. Clinical interview was conducted at pre-therapy and at the
end of therapy to assess for personality disorder criteria. To gain
an understanding of participants’ qualitative experience of par-
ticipating in ST-g, a focus group was conducted at the end of
treatment.
The focus group provided participants with an opportunity to
discuss relevant aspects of their experience participating in the
ST-g. The focus group was facilitated by the project supervisor.
The focus group session was audio and video recorded.
STATISTICAL ANALYSES
Following visual inspection of the data, a repeated measures anal-
ysis of variance (ANOVA) was conducted on all questionnaire
measures across the four trial periods (pre, mid, post, and follow-
up), and the results of the test are shown in Table 3. To investigate
the strength of treatment effects based on all outcome measures,
Cohens d was calculated. An effect size of 0.2 is considered small,
0.5 is moderate, and 0.8 and above is considered large (Kinnear
and Gray, 2008). Due to the single group design, correlation coef-
ficients, and t-test statistics for the sample and sample size at
each of the time points were considered when calculating the
effect sizes. Due to a lack of normative data available on other
measures, reliable change and clinical significance was calculated
only for the Global Symptom Index (GSI) scale of the SCL-90-R
and the SMI. We used the Jacobsen and Truax (1991) approach,
where clinical significance was calculated only if reliable change
was established. To measure therapy success we used Lambert
et al.’s (2008) classification of patients as recovered, improved,
unchanged or deteriorated.
RESULTS
ATTRITION
Two participants dropped out of therapy. The first participant
dropped out of the group at session three. Feedback provided
by this participant suggested that this was due to high levels of
shame related to returning to the group after missing a session,
and difficulty tolerating the distress associated with working on
schemas and maladaptive coping strategies whilst moving house
and working full-time. The second participant dropped out at
session 16. The participant indicated that this was due to strong
feelings of guilt associated with having missed multiple group ses-
sions which triggered a sense of shame and self-criticism for “not
putting in enough effort.”
The participants who dropped out reported significantly fewer
avoidant personality disorder symptoms at the start of treatment
compared with those who completed group therapy: t(6) = 4.44,
p = 0.004 (MCMI-III). The participants who dropped out had
a primary diagnosis of BPD and therefore differed diagnostically
from the six participants who completed treatment. There were
no significant differences between the participants who dropped
out and those who remained in group therapy in terms of ini-
tial schema and mode severity ratings, depression and anxiety
scores and general psychological distress (YSQ-S2: t(6) = 0.56,
p = 0.59; SMI maladaptive modes: t(6) = 0.09, p = 0.93; SMI
adaptive modes: t(6) = 0.23, p = 0.51; depression: t(6) = 1.27,
p = 0.25; anxiety: t(6) = 1.71, p = 0.14; general psychological
distress: t(6) = 1.51, p = 0.24). The participants who dropped
out were excluded from the analyses and the analyses were carried
out on treatment completers only.
VISUAL INSPECTION
Visual inspection of the data reveals that at the end of treatment,
four clients no longer met criteria for avoidant personality dis-
order based on scores on the MCMI-III (Millon et al., 2006)
(Figure 1). These treatment gains were maintained at 6-month
follow-up. At 6-month follow-up a fifth group member no longer
met criteria for avoidant personality disorder. These findings are
consistent with client self reports of improved daily functioning
and reduced avoidant coping behaviors. Pre-post scores also show
a large reduction in depression and anxiety levels. The six clients
who completed treatment no longer met criteria for depression at
post-treatment. These treatment gains were not only maintained
at 6-month follow-up but continued to decline. For three clients,
anxiety symptoms reduced to the non-clinical range.
Frontiers in Psychology | Psychology for Clinical Settings January 2015 | Volume 5 | Article 1592 | 4
Skewes et al. Schema group for personality disorders
Visual inspection of the SMI group mean scores indicates a
trend for the Detached Protector, Compliant Surrenderer and
Vulnerable Child to reduce across treatment with a slight increase
in the Vulnerable Child from post to follow-up (Figure 2). The
Happy Child and Healthy Adult increased across treatment with
a slight decrease in the Happy Child mode from post to follow-
up (Figure 3). Total YSQ-S2 scores show improvement across
treatment phases (Figure 4). Group scores on the Global Severity
Index (GSI) of the SCL-90-R showed a downward trend across all
treatment phases (Figure 4).
CROSS-SECTIONAL ASSOCIATIONS AMONG STUDY VARIABLES
First we determined Pearson correlations among scores of the
GSI, YSQ-S2 (total score), SMI adaptive modes and SMI mal-
adaptive modes before therapy. As can be seen in Table 2, there
was a significant association between symptomatic distress as
assessed by the GSI of the SCL-90-R and YSQ-S2 at baseline (r =
0.82, p < 0.05). Moreover, adaptive schema modes were nega-
tively related to YSQ-S2 total scores (r = −0.90, p < 0.05). There
was also a significant association between avoidant scores and
maladaptive schemamodes (r = 0.90, p < 0.05). The other study
variables did not correlate with each other.
FIGURE 1 | MCMI-III Avoidant PD, Anxiety, and Depression means from
pre to post-treatment, and follow-up. Scores above 85 indicate the
persistent presence of personality disorder indicators.
FIGURE 2 | SMI maladaptive modes group means from pre-treatment
through mid-, post-, and follow-up.
As the study aimed to investigate change in the maladaptive
schemas of the participants across treatment phases, the results
of the repeated measures ANOVA for the YSQ-S2 indicated a sig-
nificant time effect: F(1.36,6.82) = 27.43; p = 0.001. Therefore, on
the basis of the repeated measures ANOVA, the findings suggest
FIGURE 3 | SMI adaptive modes group means from pre-treatment
through mid-, post-, and follow-up.
FIGURE 4 | Total YSQ-S2 and GSI group means from pre-treatment
through mid-, post-, and follow-up.
Table 2 | Pearson correlations between GSI scores, depression,
anxiety, avoidant, YSQ-S2, and SMI at baseline.
Measure 1 2 3 4 5 6 7
1. GSI
2. YSQ-S2 0.60
3. SMI maladaptive 0.82* 0.69
4. SMI adaptive −0.68 −0.90* −0.7
5. Depression −0.06 0.31 0.08 0.13
6. Anxiety −0.13 −0.60 −0.5 0.27 −0.81
7. Avoidant 0.77 0.63 0.90* −0.63 0.22 −0.60
The diagonal shows correlation coefficients; N = 6; GSI, global symptom index
of the SCL-90-R; YSQ-S2, YSQ-S2 total score; SMI Maladaptive, Schema Mode
Inventory total score of maladaptive schema modes, SMI Adaptive, Schema
Mode Inventory total score of adaptive schema modes; *Correlation significant
at p < 0.05 (two-tailed).
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that the group’s scores as a whole significantly improved for five of
seven of the questionnaire measures (the YSQ-S2, the MCMI-III
avoidant subscale, the MCMI-III depression subscale, the SMI
maladaptive modes and the GSI of the SCL-90-R). The group
scores of the Anxiety component of the MCMI-III showed a pos-
itive trend, though not statistically significant. The group scores
of the SMI adaptive modes showed a trend for the SMI adaptive
modes to increase across treatment, with a slight decrease in the
SMI adaptive modes from post to follow-up.
Effect size (d) calculations in all questionnaire measures are
shown in Table 4. Effect sizes between pre-therapy and post-
therapy, and pre-therapy and follow-up were all large. Effect sizes
from post to follow-up were small to moderate.
Reliable change and clinical significance were calculated for
the SMI and the GSI of the SCL-90-R. For the SMI adaptive
modes, from pre-therapy to post-therapy, two (33.33%) par-
ticipants recovered, one (16.67%) improved, and three (50%)
remained the same. For the SMI maladaptive modes, from pre-
therapy to post-therapy, one (16.67%) participant recovered,
and five (83.33%) improved. For the GSI, from pre-therapy
to post-therapy, two (33.33%) participants recovered and four
(66.67%) improved. By follow-up, three (50%) participants
recovered, two (33.33%) improved and one (16.67%) remained
unchanged (one participant improved from pre-therapy to post-
therapy, but due to an increase in scores from post-therapy to
follow-up was considered unchanged overall from pre-therapy to
follow-up).
QUALITATIVE ANALYSIS
The video recorded data (of the focus group) was viewed a
number of times and themes were identified and agreed upon
by all authors. Themes were selected on the basis of frequency.
Illustrative verbatim quotes are shown with the relevant themes
below. Data analysis revealed four overarching themes: (1) the
normalizing effect of ST-g, (2) ST-g actively challenges schemas,
(3) disinhibition effect of ST-g, and (4) motivational influence of
ST-g.
THE NORMALIZING EFFECT OF ST-g
Nearly all participants reported that ST-g normalized their
schemas and associated emotional experiences. For instance:
“Everyone has schemas.”
“When I see that I can be compassionate toward others who
have schemas, I then start to challenge my own.”
ST-g ACTIVELY CHALLENGES SCHEMAS
Participants explained that ST-g increases understanding of self
through observation of others and allows direct experience in
practicing challenging schemas just by attending. Some verbatim
quotes that illustrate this are the following:
One participant with the social isolation schema reported
“When I noticed others sharing and expressing themselves, it
helped me feel safe enough to participate. Seeing others with
similar schemas helps me feel I am similar to others.”
Another participant with an entitlement schema reported “I
notice others’ needs more.”
A participant with the self-sacrifice schema said “I began to
think about what I need from other group members.”
DISINHIBITION EFFECT OF ST-g
Another theme frequently endorsed by participants was that
the group actually encourages and evokes self-expression. For
example:
Table 3 | Means, standard deviations, F statistics and p-value’s of all questionnaire measures as a result of the repeated measures ANOVA.
Measure Pre (SD) Mid (SD) Post (SD) Follow-up (SD) F (p-value)
GSI 53 (6.54) 49.83 (5.71) 46 (6.72) 45.50 (6.57) 6.37, p = 0.03*
YSQ-S2 52.87 (5.84) 47.5 (6.37) 40.63 (5.26) 37.90 (5.23) 27.43, p = 0.001**
SMI maladaptive 36.68 (4.15) 33.08 (1.89) 30.46 (3.15) 30.74 (2.87) 8.49, p = 0.02*
SMI adaptive 6.02 (0.91) 6.88 (1.23) 7.35 (1.10) 7.27 (1.12) 3.56, p = 0.10
Depression 89.50 (3.56) 60.5 (13.63) 53.33 (20.67) 19.86, p = 0.002*
Anxiety 94.17 (6.62) 74 (36.89) 73 (36.11) 2.23, p = 0.19
Avoidant 107.5 (8.43) 77.67 (11.52) 77 (11.22) 36.33, p < 0.001**
*Indicates significance to the 0.05 level; **Indicates significance to the 0.01 level.
Table 4 | Effect sizes (d) in all questionnaire measures, showing both pre to post effects and pre to follow-up effects.
Treatment period YSQ-S2 (d) Avoidant (d) Anxiety (d) Depression (d) GSI (d) SMI adaptive (d) SMI maladaptive (d)
Pre to post 2.20 2.96 0.76 2.91 1.06 1.32 1.69
Pre to follow-up 2.70 3.07 0.82 2.44 1.14 1.22 1.66
Post to follow-up 0.52 0.06 0.03 0.41 0.08 (0.07) (0.09)
Use of brackets ( ) denotes that the change demonstrated moved in the opposite direction from what would be clinically desirable (i.e., the group mean score
worsened over time). Guideline cut-off scores for the magnitude of effect size: 0.2–0.5 = small; 0.5–0.8 = medium; 0.8 and above = large.
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“Seeing others being vulnerable and not judging each other,
allowed me to feel safe to express my feelings and needs.”
MOTIVATIONAL INFLUENCE OF ST-g
A majority of participants noted that ST-g motivated them to
make behavioral changes. For instance:
“Seeing others make progress has more impact on me
(compared to individual therapy)”
“others’ progress spurs me on.”
“There is a lot of emphasis on the steps needed to make
(behavioral) changes and build my healthy self.”
DISCUSSION
This study aimed to investigate the feasibility, acceptability and
preliminary efficacy of ST-g in a sample of eight participants
with mixed personality disorders and comorbidity. A large effect
size was found for the group between pre-therapy and follow-
up for all measures. All outcome measures showed changes with
large effect sizes in avoidant personality disorder symptom sever-
ity, and depression and anxiety levels between pre-therapy and
follow-up. Four participants achieved a loss of personality disor-
der diagnosis at the end of therapy. By follow-up, five participants
had achieved a loss of diagnosis, suggesting that participants
derived ongoing benefits from the group even after treatment
ended. Six participants no longer met criteria for depression at
the end of treatment and this was maintained for all participants
at 6-month follow-up. Clinically significant change on the GSI
at follow-up showed that a majority of participants had recov-
ered. For the SMImaladaptivemodes, themajority of participants
showed improvement at follow-up. Clinically significant change
for the SMI adaptive modes at follow-up showed that 40% of the
participants had recovered.
One of the main aims of ST is to help patients to reduce mal-
adaptive coping modes so that they can begin to find healthy ways
of enabling their emotional needs to be met, both by others and
themselves (Young et al., 2003). In this study, the largest change
pre-post was in the Detached Protector mode, suggesting a reduc-
tion in numbing or distancing as a way of dealing with emotions
and relationships. As patients notice an initial increase in aware-
ness of overwhelming emotions, they often initially fall back on
old familiar coping modes as a way of managing. It is a common
clinical observation that participants’ scores on the Vulnerable
Child mode (i.e., the state in which they are in touch with emo-
tions) often increase across the first-half of therapy as clients
become less emotionally detached and gain increased awareness
of their early maladaptive schemas and schema modes. It seems
possible that pre-treatment scores on the SMI may not in fact
reflect actual mode severity (i.e., under rating). Interestingly, par-
ticipants rated themselves with relatively high levels of “Healthy
Adult” mode at pre-treatment, in spite of significant pathology
and longstanding psychological difficulties. Clinical observations
in the group suggested that this may well have indicated an ini-
tial confusion by group participants over the differences between
healthy and avoidant coping, resulting in a tendency to overes-
timate their Healthy Adult mode. Apparent limited change in
maladaptive schemamodes may also indicate increased awareness
of emotional states across therapy. The significant reduction in
DSM-IV-TR avoidant personality disorder criteria may reflect
behavioral change, whereas longer treatment may be required
to achieve change at an emotional level associated with schema
modes. It may be that more than 20 sessions is required to acti-
vate lasting emotional change in this population. Future studies
should increase the number of sessions and duration of sessions
in order to allow more scope for experiential work to take place in
the group context.
In this study two participants dropped out of therapy.
Comparison with attrition rates in other group studies suggests
that this is may be a relatively low attrition rate and is compa-
rable with similar studies using ST (Davis et al., 2006; Simpson
et al., 2010; van Vreeswijk et al., 2012). The two participants
who dropped out in this study had a primary diagnosis of BPD
(and fewer symptoms of avoidant personality disorder than other
participants) and therefore differed diagnostically from the six
participants who completed treatment. It seems plausible that
when these participants expressed emotions openly in early ses-
sions, at a time when the rest of the participants were detached
from their feelings, this may have triggered social isolation and
defectiveness schemas which may in turn have been experienced
as alienating for these two participants. This finding may have
important clinical implications regarding the potential value of
ensuring that participants are screened carefully to ensure that all
share schema mode constellations with at least half of the group,
in order to prevent re-experiencing of old patterns in relation to
feeling excluded or different in someway from others. In addition,
addressing shame explicitlymay be important in helping clients to
manage feelings of shame that may otherwise contribute to early
drop-out. Lastly, encouraging clients to connect with other group
members should be a priority in order to prevent re-experiencing
of old patterns related to feeling interpersonally disconnected or
isolated.
The clinical improvements demonstrated in this study indi-
cate that ST delivered in a group setting may hold promise for
participants with different personality disorders and high levels
of comorbidity. It has been hypothesized that there may be spe-
cific factors operating in a group setting that challenge schemas
at a group-process level (Simpson et al., 2010). The qualitative
feedback collected in this study, indicates that the group helps
to normalize participants’ psychological experiences and difficul-
ties and promotes self-expression and self-disclosure, which, in
turn, reduces inhibition (i.e., bypasses the “Detached Protector”).
The group fostered the development of psychological insight
and increased self-awareness as participants observed their own
schemas in other participants’ and the way those schemas influ-
ence interaction between group members. The unique social
component of the group directly challenges a number of partic-
ipants’ schemas by facilitating social interaction and helping to
build new healthier models of social relationships that challenge
participants’ existing life patterns.
The group also motivated participants to make behavioral
changes that they had been unable to make during individual
therapy. Participants felt motivated by directly observing other
participants’ progress. Some of the themes identified through the
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focus group have been previously identified in the literature (e.g.,
Farrell et al., 2009; Simpson et al., 2010), such as the normalizing
and de-shaming aspect of ST-g. These potential additive effects
of group therapy could be explored further by comparing group
with individual schema therapy.
Limitations of this study include a small sample size and
a lack of a longer follow-up period. Moreover, the fact that a
mixed personality disorder group was used reduced our num-
ber of participants further. If our study had focused on a single
diagnostic group, this may have allowed greater standardiza-
tion of assessments and facilitated the use of specific cut-off
points for inclusion in the study, thereby improving the method-
ological robustness of the study. However, this may also have
reduced the generalizability of this study to general clinical pop-
ulations seen within health and hospital-based clinics that are
often composed of heterogeneous client groups. In addition,
due to the fact that this was a small pilot study that was con-
ducted to determine the feasibility and efficacy of short-term
ST-g with a mixed personality disorder population, a compar-
ative control group was not included. As such, it is not pos-
sible to determine from these findings the extent to which the
results are due to participants’ response to therapy in general
or to ST-g specifically or to other variables. Although DSM-IV
criteria were utilized when interviewing and diagnosing psychi-
atric disorders, a formal diagnostic interview such as the SCID-I
and II would have been a more robust means of assessment at
pre-treatment. Additionally, in this study, we did not set a prede-
termined MCMI-III cut off point for inclusion. Finally, although
treatment fidelity was rated by accredited schema therapists regu-
larly throughout the study, no formal ST-adherence rating was
done. Future studies in this area could improve on our proce-
dure by assigning random tapes to raters not involved in the
study. If it was a large trial, we would complete intention-to-
treat analyses by including participants who dropped-out in all
analyses.
This naturalistic pilot study allows greater exploration of the
level of change possible over a 20 week schema therapy group
with a mixed personality disorder sample. Naturalistic designs are
clinically useful and have high ecological validity, which can allow
results to be generalized to patients generally seen in typical clini-
cal settings (i.e., community mental health teams, hospital wards)
(Lincoln and Guba, 1985; van Vreeswijk et al., 2012). In addi-
tion, this study contributes valuable data which will inform the
development of a larger RCT with this population. In particu-
lar, this study may have implications for the significant number
of patients with personality disorders who may not respond to
conventional treatments offered within many health service set-
tings. This study contributes to a growing body of literature that
suggests that ST-g shows promise as an intervention which may
stimulate avoidant coping patterns through experiential, cogni-
tive and behavioral group processes, many of which appear to be
unique to working in a group setting.
REFERENCES
American Psychiatric Association. (1994). Diagnostic and Statistical Manual of
Mental Disorder, 4th Edn. Washington, DC: American Psychiatric Association.
Ball, S. A., MacCarelli, L. M., Lapaglia, D. M., and Ostrowski, M. J. (2011).
Randomized trial of dual-focused vs. single-focused individual therapy for
personality disorders and substance dependence. J. Nerv. Ment. Dis. 199,
319–328. doi: 10.1097/NMD.0b013e3182174e6f
Bamelis, L. L. M., Evers, S. M. A. A., Spinhoven, P., and Arntz, A. R. (2014).
Results of a multicenter randomized controlled trial of the clinical effectiveness
of schema therapy for personality disorders. Am. J. Psychiatry 171, 305–322. doi:
10.1176/appi.ajp.2013.12040518
Craig, R. J. (2005). New Directions in Interpreting the Millon Clinical Multiaxial
Inventory. New York, NY: Wiley.
Davis, S., Hooke, G. R., and Page, A. C. (2006). Identifying and targeting predictors
of drop-out from group cognitive behaviour therapy. Aust. J. Psychol. 58, 48–56.
doi: 10.1080/00049530500504096
Derogatis, L. R., Lipman, R. S., and Covi, L. (1973). SCL-90, an outpa-
tient psychiatric rating scale-preliminary report. Psychopharmacol. Bull. 9,
13–28.
Dickhaut, V., and Arntz, A. (2013). Combined group and individual schema ther-
apy for borderline personality disorder: a pilot study. J. Behav. Ther. Exp.
Psychiatry 3, 242–251. doi: 10.1016/j.jbtep.2013.11.004
Farrell, J. M., Reiss, N., and Shaw, I. (2014). The Schema Therapy Clinician’s Guide:
A Complete Resource for Building andDelivering Individual, Group and Integrated
Schema Mode Treatment Programs. Chichester; Hoboken: John Wiley & Sons.
Farrell, J. M., and Shaw, I. A. (1994). Emotional awareness training: a prerequisite
to effective cognitive-behavioral treatment of borderline personality disorder.
Cogn. Behav. Pract. 1, 71–91.
Farrell, J. M., and Shaw, I. A. (2012). Group Schema Therapy for Borderline
Personality Disorder: A Step-By-Step Treatment Manual with Patient Workbook.
New York, NY: Wiley.
Farrell, J. M., Shaw, I. A., and Webber, M. (2009). A schema-focused approach
to group psycho-therapy for outpatients with borderline personality disor-
der: a randomized controlled. J. Behav. Ther. Exp. Psychiatry 40, 317–328. doi:
10.1016/j.jbtep.2009.01.002
Giesen-Bloo, J., van Dyck, R., Spinhoven, P., van Tilburg, W., Dirksen, C., van
Asselt, T., et al. (2006). Outpatient psychotherapy for borderline personality
disorder. Randomized trial of schema-focused therapy versus transference-
focused psychotherapy. Arch. Gen. Psychiatry 63, 649–658. doi: 10.1001/arch-
psyc.63.6.649
Greeven, A., Spinhoven, P., Korrelboom, K., van Giezen, A. E., and Arntz, A.
(2013). “Group schema therapy versus group cognitive behavioral therapy
for social anxiety disorder with comorbid avoidant personality disorder,” in
Trialregister.nl [Internet]. NTR number: NTR3921. Available online at: http://
www.trialregister.nl/trialreg/admin/rctview.asp?TC=3921
Jacobsen, N. S., and Truax, P. (1991). Clinical significance: a statistical approach to
defining meaningful change in psychotherapy research. J. Consult. Clin. Psychol.
59, 12–19.
Kinnear, P. R., and Gray, C. D. (2008). SPSS 15 Made Simple. Hove; New York:
Psychology Press.
Kristeller, J., Baer, R., and Quillian-Wolever, R. (2006). “Mindfulness based
approaches to eating disorders,” inMindfulness-Based Treatment Approaches, ed
R. A. Baer (San Diego, CA: Elsevier), 75–91.
Lambert, M. J., Hansen, N. B., and Bauer, S. (2008). “Assessing the clinical sig-
nificance of outcome results,” in Evidence-based Outcome Research: A Practical
Guide to Conducting Randomized Controlled Trials for Psychosocial Interventions,
eds A. Nezu and C. M. Nezu (New York, NY: Oxford University Press. BS),
359–378.
Lincoln, Y. S., and Guba, E. G. (1985). Naturalistic Enquiry. Thousand Oaks, CA:
Sage Publications, Inc.
Lobbestael, J., van Vreeswijk, M. F., Spinhoven, P., Schouten, E., and Arntz, A.
(2010). The reliability and validity of the schema mode inventory (SMI). Cogn.
Behav. Psychother. 38, 437–458. doi: 10.1017/S1352465810000226
Masley, S., Gillanders, D., Simpson, S., and Taylor, M. (2011). A systematic review
of the evidence base for schema therapy. Cogn. Behav. Ther. 19, 1–18. doi:
10.1080/16506073.2011.614274
Millon, T., Davis, R. D., and Millon, C. (1997). MCMI-III Manual, 2nd Edn.
Minneapolis, MN: National Computer Systems.
Millon, T., Millon, C., Davis, R., and Grossman, S. (2006). MCMI-III Manual, 3rd
Edn.Minneapolis, MN: Pearson Education, Inc.
Müller, J. M., Postert, C., Furniss, T., Beyer, T., and Achtergarde, S. (2010).
Comparison of eleven short forms of the Symptom Checklist Revised (SCL-
90-R). J. Psychopathol. Behav. Assess. 32, 246–254. doi: 10.1007/s10862-009-
9141-5
Frontiers in Psychology | Psychology for Clinical Settings January 2015 | Volume 5 | Article 1592 | 8
Skewes et al. Schema group for personality disorders
Nadort, M., Arntz, A., Smit, J., Giesen-Bloo, J., Eikelenbooma, M., Spinhoven,
P., et al. (2009). Implementation of outpatient schema therapy for border-
line personality disorder with versus without crisis support by the therapist
outside office hours: a randomized trial. Behav. Res. Ther. 47, 961–973. doi:
10.1016/j.brat.2009.07.013
National Institute of Clinical Excellence. (2009). CG78 Borderline Personality
Disorder (BPD): NICE Guideline. Accessed online at: http://publications.nice.
org.uk/borderline-personality-disorder-cg78
Renner, F., van Goor, M., Huibers, M., Arntz, A., Butz, B., and Bernstein,
D. (2013). Short-term group schema cognitive-behavioral therapy for young
adults with personality disorders and personality disorder features: asso-
ciations with changes in symptomatic distress, schemas, schema modes
and coping styles. Behav. Res. Ther. 51, 487–492. doi: 10.1016/j.brat.2013.
05.011
Rijkeboer, M. M., van den Bergh, H., and van den Bout, J. (2005). Stability and
discriminative power of the Young Schema Questionnaire. J. Behav. Ther. Exp.
Psychiatry 36, 129–144. doi: 10.1016/j.jbtep.2004.08.005
Schmidt, N. B., Joiner, T. E., Young, J. E., and Telch, M. J. (1995). The schema
questionnaire: Investigation of psychometric properties and the hierarchical
structure of a measure of maladaptive schemas. Cogn. Ther. Res. 19, 295–321.
Simpson, S. G., Morrow, E., van Vreeswijk, M. F., and Reid, C. (2010). Group
schema therapy for eating disorders: a pilot study. Front. Psychol. 1:182. doi:
10.3389/fpsyg.2010.00182
van Asselt, A. D. I., Dirksen, C. D., Arntz, A., Giesen-Bloo, J. H., van Dyck,
R., Spinhoven, P., et al. (2008). Outpatient psychotherapy for borderline
personality disorder: cost effectiveness of schema-focused therapy versus
transference focused psychotherapy. Br. J. Psychiatry 192, 450–457. doi:
10.1192/bjp.bp.106.033597
van Vreeswijk, M. F., and Broersen, J. (2006). Schemagerichte Therapie in Groepen:
Handleiding Voor Therapeuten. Houten: Bohn Stafleu van Loghum.
van Vreeswijk, M. F., and Broersen, J. (2013). Kortdurende Schemagroeps-Therapie:
Cognitief Gedragstherapeutische Technieken Deel Handleiding, Rev. Edn.Houten:
Bohn Stafleu van Loghum.
van Vreeswijk, M. F., Broersen, J., and Schurink, G. (2014).Mindfulness and Schema
Therapy: A Practical Guide. Oxford, Wiley-Blackwell.
van Vreeswijk, M. F., Spinhoven, P., Eurelings-Bontekoe, E. H. M., and Broersen,
J. (2012). Changes in symptom severity, schemas and modes in heterogeneous
psychiatric patient groups following short term schema cognitive-behavioural
group therapy: a naturalistic pre-post treatment design in an outpatient clinic.
Clin. Psychol. Psychother. 21, 29–38. doi: 10.1002/cpp.1813
Videler, A. C., Rossi, G., Schoevaars, M., van der Feltz-Cornelis, C. M., and
van Alphen, S. P. J. (2014). Effects of schema group therapy in older
outpatients: a proof of concept study. Int. Psychogeriatr. 26, 1709–1717. doi:
10.1017/S1041610214001264
Young, J. E. (1998). The Young Schema Questionnaire: Short Form. Accessed online
at: http://home.sprynet.com/sprynet/schema/ysqs1.htm
Young, J. E., Arntz, A., Atkinson, T., Lobbestael, J., Weishaar, M. E., van Vreeswijk,
M. F., et al. (2007). The Schema Mode Inventory (SMI). New York, NY: Schema
Therapy Institute.
Young, J. E., and Brown, G. (1994). “Young Schema Questionnaire,” in Cognitive
Therapy for Personality Disorders: A Schema-Focused Approach, Rev. Edn.
(Sarasota, FL: Professional Resource Press), 63–76.
Young, J. E., Klosko, J., andWeishaar, M. E. (2003). Schema Therapy: A Practitioners
Guide. New York, NY: Guilford.
Zimmerman, M., Rothschild, L., and Chelminski, I. (2005). The prevalence of
DSM-IV personality disorders in psychiatric outpatients. Am. J. Psychiatry 162,
1911–1918. doi: 10.1176/appi.ajp.162.10.1911
Conflict of Interest Statement: The authors declare that the research was con-
ducted in the absence of any commercial or financial relationships that could be
construed as a potential conflict of interest.
Received: 28 October 2014; accepted: 27 December 2014; published online: 22 January
2015.
Citation: Skewes SA, Samson RA, Simpson SG and van Vreeswijk M (2015) Short-
term group schema therapy for mixed personality disorders: a pilot study. Front.
Psychol. 5:1592. doi: 10.3389/fpsyg.2014.01592
This article was submitted to Psychology for Clinical Settings, a section of the journal
Frontiers in Psychology.
Copyright © 2015 Skewes, Samson, Simpson and van Vreeswijk. This is an open-
access article distributed under the terms of the Creative Commons Attribution
License (CC BY). The use, distribution or reproduction in other forums is permit-
ted, provided the original author(s) or licensor are credited and that the original
publication in this journal is cited, in accordance with accepted academic practice.
No use, distribution or reproduction is permitted which does not comply with these
terms.
www.frontiersin.org January 2015 | Volume 5 | Article 1592 | 9
